- Home
- SGMT vs CTW Comparison
SGMT vs CTW Comparison
Compare SGMT & CTW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SGMT | CTW |
|---|---|---|
| Founded | 2006 | 2013 |
| Country | United States | Japan |
| Employees | N/A | N/A |
| Industry | | EDP Services |
| Sector | | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 169.4M | 162.2M |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | SGMT | CTW |
|---|---|---|
| Price | $7.75 | $2.45 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 8 | 0 |
| Target Price | ★ $26.13 | N/A |
| AVG Volume (30 Days) | ★ 1.4M | 13.3K |
| Earning Date | 05-14-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $2,000,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $22.41 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $4.50 | $1.10 |
| 52 Week High | $11.41 | $3.14 |
Technical Indicators
Market Signals| Indicator | SGMT | CTW |
|---|---|---|
| Relative Strength Index (RSI) | 58.62 | 48.50 |
| Support Level | $7.04 | $1.98 |
| Resistance Level | $8.80 | $2.52 |
| Average True Range (ATR) | 0.50 | 0.30 |
| MACD | 0.03 | -0.00 |
| Stochastic Oscillator | 74.60 | 36.63 |
Price Performance
Historical ComparisonAbout SGMT Sagimet Biosciences Inc. Series A
Sagimet Biosciences Inc is a clinical-stage biopharmaceutical company dedicated to developing a portfolio of in-house discovered, selective fatty acid synthase (FASN) inhibitors aimed at treating diseases that arise from dysfunctional lipid metabolism pathways. The company's drug candidate, denifanstat, is an oral, once-daily pill that serves as a selective FASN inhibitor under development for treating nonalcoholic steatohepatitis (NASH). The company functions as a single business segment, focusing on the development and commercialization of therapeutics for MASH and other diseases where FASN plays a pathogenic role.
About CTW CTW Cayman Class A Ordinary Shares
CTW operates as a gaming platform company providing instant access to free-to-play, browser-based games inspired by popular Japanese animation, including "So I'm a Spider, So What? Ruler of the Labyrinth, Arifureta: From Commonplace to World's Strongest - Rebellion Soul", and "Queen's Blade Limit Break". CTW delivers these games through its flagship HTML5 platform, G123.jp.